FDx Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-1,657
| Closed | -$236K | – | 724 |
|
2019
Q2 | $236K | Buy |
1,657
+202
| +14% | +$28.8K | 0.01% | 716 |
|
2019
Q1 | $208K | Buy |
+1,455
| New | +$208K | 0.01% | 726 |
|
2018
Q4 | – | Sell |
-1,536
| Closed | -$258K | – | 692 |
|
2018
Q3 | $258K | Buy |
1,536
+121
| +9% | +$20.3K | 0.01% | 750 |
|
2018
Q2 | $244K | Buy |
+1,415
| New | +$244K | 0.01% | 793 |
|
2016
Q4 | – | Sell |
-4,755
| Closed | -$578K | – | 1142 |
|
2016
Q3 | $578K | Sell |
4,755
-1,181
| -20% | -$144K | 0.02% | 572 |
|
2016
Q2 | $839K | Sell |
5,936
-543
| -8% | -$76.7K | 0.04% | 416 |
|
2016
Q1 | $846K | Sell |
6,479
-1,602
| -20% | -$209K | 0.04% | 420 |
|
2015
Q4 | $1.14M | Buy |
8,081
+1,621
| +25% | +$228K | 0.05% | 313 |
|
2015
Q3 | $858K | Sell |
6,460
-3,776
| -37% | -$501K | 0.07% | 288 |
|
2015
Q2 | $1.8M | Buy |
10,236
+2,336
| +30% | +$411K | 0.09% | 202 |
|
2015
Q1 | $1.37M | Buy |
7,900
+567
| +8% | +$98.4K | 0.03% | 470 |
|
2014
Q4 | $1.2M | Buy |
7,333
+199
| +3% | +$32.6K | 0.07% | 251 |
|
2014
Q3 | $1.15M | Buy |
7,134
+2,482
| +53% | +$398K | 0.07% | 286 |
|
2014
Q2 | $684K | Buy |
4,652
+1,887
| +68% | +$277K | 0.04% | 467 |
|
2014
Q1 | $383K | Sell |
2,765
-1,099
| -28% | -$152K | 0.03% | 524 |
|
2013
Q4 | $490K | Sell |
3,864
-90
| -2% | -$11.4K | 0.05% | 367 |
|
2013
Q3 | $364K | Buy |
+3,954
| New | +$364K | 0.04% | 373 |
|